Silo Pharma, Inc.·4

May 28, 4:30 PM ET

Weisblum Eric 4

4 · Silo Pharma, Inc. · Filed May 28, 2025

Insider Transaction Report

Form 4
Period: 2025-05-27
Weisblum Eric
DirectorPres, Chief Compliance Officer
Transactions
  • Purchase

    Common Stock

    2025-05-27$0.43/sh+10,000$4,329197,932 total
Footnotes (1)
  • [F1]This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $0.42 to $0.45, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    ownership.xmlPrimary